Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...
Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...
The biggest figures in artificial intelligence sparred over the dangers of the rapidly advancing technology at the World ...
"There's no real point in having regulation only in one region of the world, because AI sort of is across borders; it's going ...
Business Insider's diary takes you behind the scenes on day three of the World Economic Forum in Davos.
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
This year’s Nobel Prizes were a “watershed moment” for artificial intelligence, according to Demis Hassabis, a co-winner of this year’s prize in chemistry. Hassabis, 48, CEO and co-founder ...
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...
At Meta, the metaverse will take a backseat to $65 billion in AI spending. Microsoft plans to on AI-enabled data centers in ...
Here’s how DeepMind’s AlphaFold is accelerating this research exponentially. In 1997, while Demis Hassabis was a student at Cambridge, IBM Deep Blue, a chess program, defeated grandmaster ...